Literature DB >> 14604601

Perception of males' aging symptoms, health and well-being in elderly community-dwelling men is not related to circulating androgen levels.

G T'Sjoen1, S Goemaere, M De Meyere, J M Kaufman.   

Abstract

Aging in men is associated with a progressive but variable decline in androgen production. In aging men there is also an increased occurrence of symptoms such as lack of concentration, nervousness, impaired memory, depressive mood, insomnia, lack of energy and general sense of well-being, decreased libido and erectile dysfunction, periodic sweating, bone and joint complaints, reduction of strength and increased adiposity. This ill-defined male climacterium syndrome is often referred to as "andropause", with the underlying implication that it is at least in part related to (relative) androgen deficiency. Recently an "aging males" symptoms' (AMS) rating scale was developed aimed at a more systematic description of severity of symptoms related to a clinically defined "male climacteric". We studied the relationship of male climacteric symptoms as assessed by the AMS with androgen levels and other questionnaires assessing the perception of health and well-being. Serum levels of sex steroids, sex hormone binding globulin and gonadotropins were measured in blood samples of 161 healthy, ambulatory, elderly men, aged 74-89 years who also completed the AMS scale. Mean value of total, free and bioavailable testosterone in this group was 401.6, 6.8 and 151.4 ng/dl, respectively, with 24.7, 32.4 and 52.2% of the values under the normal range for young men. The results of the AMS scores mostly suggested mild psychological and mild to moderate somatovegetative symptoms. However, clear sexual symptoms were reported in 88% of cases. None of the three AMS domain scale scores significantly correlated with testosterone, free testosterone or bioavailable testosterone. Significant correlations were observed between results for the AMS scores and those for other health questionnaires, but none of the subscores for the latter questionnaires correlated with androgen serum levels. In conclusion, the results of this study have shown that, as assessed by the AMS, healthy ambulatory elderly males over 70 had a high perception of sexual symptoms with mild psychological and mild to moderate somatovegetative symptoms. These data failed to support the view that in healthy elderly men, "climacteric symptoms" can predict androgen levels.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14604601     DOI: 10.1016/s0306-4530(03)00023-4

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  8 in total

1.  Effect of cardiac resynchronization therapy on libido and erectile dysfunction.

Authors:  Ahmet Vural; Aysen Agacdiken; Umut Celikyurt; Melih Culha; Goksel Kahraman; Guliz Kozdag; Dilek Ural
Journal:  Clin Cardiol       Date:  2011-06-02       Impact factor: 2.882

2.  Modification Effects of Changes in Job Demands on Associations Between Changes in Testosterone Levels and Andropause Symptoms: 2-Year Follow-up Study in Male Middle-Aged Japanese Workers.

Authors:  Kumi Hirokawa; Toshiyo Taniguchi; Yasuhito Fujii; Jiro Takaki; Akizumi Tsutsumi
Journal:  Int J Behav Med       Date:  2016-08

Review 3.  Recent topics related to testosterone deficiency syndrome in Japan.

Authors:  Akira Tsujimura; Norio Nonomura
Journal:  Asian J Androl       Date:  2011-04-04       Impact factor: 3.285

4.  The Effect of Transdermal Testosterone Administration on Lower Urinary Tract Symptoms and Erectile Dysfunction: A Prospective, Randomized, Placebo-Controlled Trial.

Authors:  Cem Yucel; Mehmet Zeynel Keskin; Cetin Levent Peskircioglu
Journal:  Curr Urol       Date:  2017-11-30

5.  The benefits and risks of testosterone replacement therapy: a review.

Authors:  Nazem Bassil; Saad Alkaade; John E Morley
Journal:  Ther Clin Risk Manag       Date:  2009-06-22       Impact factor: 2.423

6.  A cross-sectional pilot study to determine the prevalence of testosterone deficiency syndrome in working population of Indian men.

Authors:  Apul Goel; Sandeep Kumar; S M Natu; D Dalela; R J Sinha; S Awasthi
Journal:  Indian J Urol       Date:  2009-04

7.  Effects of long-term androgen replacement therapy on the physical and mental statuses of aging males with late-onset hypogonadism: a multicenter randomized controlled trial in Japan (EARTH Study).

Authors:  Hiroyuki Konaka; Kazuhiro Sugimoto; Hideki Orikasa; Teruaki Iwamoto; Toshinari Takamura; Yoshiyu Takeda; Kazuyoshi Shigehara; Masashi Iijima; Eitetsu Koh; Mikio Namiki
Journal:  Asian J Androl       Date:  2016 Jan-Feb       Impact factor: 3.285

8.  Efficacy and Safety of 5-Aminolevulinic Acid for Patients with Symptoms of Late-Onset Hypogonadism: A Preliminary Study.

Authors:  Hiroki Koyasu; Shigeo Horie; Kazuhito Matsushita; Takeshi Ashizawa; Satoru Muto; Shuji Isotani; Tohru Tanaka; Motowo Nakajima; Akira Tsujimura
Journal:  World J Mens Health       Date:  2022-01-25       Impact factor: 6.494

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.